November is Prostate Cancer Awareness Month, so this month weβve interviewed MiraKindβs founder, Dr. Joanne Weidhaas, about personalizing prostate cancer treatment and how patients can personalize their treatment choices with a new…
Read More β
In November 2020, we announced that we had undertaken new research into other genetic variants that are connected to cancer. Specifically, ones that affect prostate cancer.1 Our research has produced a lot…
Read More β
Over the years, Mirakind has shared research and information about the KRAS-variant and how it can have many health implications – from cancer to autoimmunity to response to hormone replacement therapy. Now,…
Read More β
Disclaimer
Any discussion of medical management options on this website is for general informational purposes only and does not constitute a medical recommendation. All medical management decisions should be made based on consultation between each patient and his or her healthcare professional.
